← Patent-cliff monitor 9 upcoming patent cliffs Drug Ingredient Type Cliff
FENTORA FENTANYL CITRATE Small mol. Jun 2028 FENTORA FENTANYL CITRATE Small mol. Jun 2028 FENTORA FENTANYL CITRATE Small mol. Jun 2028 FENTORA FENTANYL CITRATE Small mol. Jun 2028 FENTORA FENTANYL CITRATE Small mol. Jun 2028 TREANDA BENDAMUSTINE HYDROCHLORIDE Small mol. Mar 2030 TREANDA BENDAMUSTINE HYDROCHLORIDE Small mol. Mar 2030 TREANDA BENDAMUSTINE HYDROCHLORIDE Small mol. Apr 2031 TREANDA BENDAMUSTINE HYDROCHLORIDE Small mol. Apr 2031 TRISENOX ARSENIC TRIOXIDE Small mol. — TRISENOX ARSENIC TRIOXIDE Small mol. — FENTORA FENTANYL CITRATE Small mol. — GABITRIL TIAGABINE HYDROCHLORIDE Small mol. — GABITRIL TIAGABINE HYDROCHLORIDE Small mol. — GABITRIL TIAGABINE HYDROCHLORIDE Small mol. — GABITRIL TIAGABINE HYDROCHLORIDE Small mol. — GABITRIL TIAGABINE HYDROCHLORIDE Small mol. — GABITRIL TIAGABINE HYDROCHLORIDE Small mol. — GABITRIL TIAGABINE HYDROCHLORIDE Small mol. — GABITRIL TIAGABINE HYDROCHLORIDE Small mol. — FENTANYL FENTANYL CITRATE Small mol. — FENTANYL FENTANYL CITRATE Small mol. — FENTANYL FENTANYL CITRATE Small mol. — FENTANYL FENTANYL CITRATE Small mol. — ACTIQ FENTANYL CITRATE Small mol. — ACTIQ FENTANYL CITRATE Small mol. — ACTIQ FENTANYL CITRATE Small mol. — ACTIQ FENTANYL CITRATE Small mol. — ACTIQ FENTANYL CITRATE Small mol. — ACTIQ FENTANYL CITRATE Small mol. — Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.